Company Website: http://www.BSDMedical.com
SALT LAKE CITY -- (Business Wire)

BSD Medical Corporation (NASDAQ: BSDM) (the “Company” or “BSD”) announced today that a patent has been issued to the Company for a new class of heat therapy applicators (antennas). The United States (US) patent office issued the new patent, “Transparent electromagnetic applicator and hyperthermia treatment method,” to BSD for a unique design for antennas that provides significant benefits for heat therapy applications. These novel antennas have a transparent surface, which provides the significant advantage of allowing the physician to see the skin surface through the contacting antenna during a treatment. The unique design also utilizes a significantly smaller antenna that can be combined in groups to utilize BSD’s synchronous phased array technology, which was developed by the Company to improve the delivery of heat therapy by directly targeting heating to the tumor. There are five different antenna types and sizes that are part of this new class of antenna, which allows BSD to combine up to 24 antennas into a single applicator and utilize sophisticated heating pattern steering to shape the energy field to the individual tumor. BSD has been designing heat therapy systems for 32 years and has obtained several pioneering patents for the devices, techniques and methodology used in heat therapy.

“The issuance of this patent significantly strengthens BSD’s intellectual property and position in the marketplace for heat therapy equipment,” said Paul F. Turner, Chief Technology Officer and Sr. VP at BSD. “We are proud to be able to offer another new industry leading device to the heat therapy community. BSD has been in the forefront in developing innovative technology for heat therapy applications, and we are continuing to aggressively bolster our intellectual property. There are currently five US pending patents relating to the ablation field and six US pending patents related to the hyperthermia field. When issued, these patents will be a significant addition to the extensive intellectual property already developed by BSD.”

About BSD Medical Corporation

BSD Medical Corporation develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy delivered using focused radiofrequency (RF) and microwave energy. BSD’s product lines include both hyperthermia and ablation treatment systems. BSD’s hyperthermia cancer treatment systems, which have been in use for several years in the United States, Europe and Asia, are used to treat certain tumors with heat (hyperthermia) while increasing the effectiveness of other therapies such as radiation therapy. BSD’s microwave ablation system has been developed as a stand-alone therapy to employ precision-guided microwave energy to ablate (destroy) soft tissue. The Company has developed extensive intellectual property, multiple products in the market and well established distribution in the United States, Europe and Asia. Certain of the Company’s products have received regulatory approvals and clearances in the United States, Europe and China. For further information visit BSD Medical's website at www.BSDMedical.com.

Statements contained in this press release that are not historical facts are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date.

Contacts:

BSD Medical Corporation
Dennis Gauger, 801-972-5555
Fax: 801-972-5930
investor@bsdmc.com

Source: BSD Medical Corporation